Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown
- PMID: 3514666
- DOI: 10.1016/0165-5728(86)90003-2
Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown
Abstract
Four samples of thymoma obtained from patients affected by myasthenia gravis have been immunohistologically analysed on cryostat sections using a panel of antisera and monoclonal antibodies specific for antigens which define different stages of intrathymic lymphocyte differentiation and antigens specific for different types of thymic epithelial cells (cortical, medullary). When the thymoma samples were compared to age-matched normal thymuses and hyperplastic thymuses obtained from patients with myasthenia gravis some evident microenvironmental differences could be demonstrated using these reagents. In all the thymoma samples in fact the neoplastic lobules appeared as grossly enlarged cortical-type areas, formed by accumulations of T lymphocytes exhibiting the cortical immature phenotype (TdT+, T6+, etc.) within a network of putatively neoplastic epithelial cells characterized by cortical phenotype as defined by reactivity with various monoclonal antibodies (RFD4-, MR3+). These 'cortical' epithelia showed some abnormal features such as lack or irregular distribution of HLA-DR and enhanced keratin expression. Small areas of 'medullary' differentiation could be observed in 3/4 thymoma samples. In thymic hyperplasia, on the other hand, the cortical areas appeared somewhat compressed (but comparable to those observed in normal age-matched samples) by enlarged medullary areas. The expansion of medullary areas was due to the infiltration of 'peripheral' lymphoid tissue intruding through the extraparenchymal zone and forming organized B and T areas. These observations are discussed in the light of the clinical heterogeneity observed in myasthenia gravis.
Similar articles
-
Fc gamma receptors and HLA-DR antigens on thymus cells in myasthenia gravis.J Neuroimmunol. 1986 Jan;10(3):271-8. doi: 10.1016/0165-5728(86)90107-4. J Neuroimmunol. 1986. PMID: 2934405
-
Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.Clin Immunol Immunopathol. 1992 Jan;62(1 Pt 1):91-6. doi: 10.1016/0090-1229(92)90027-l. Clin Immunol Immunopathol. 1992. PMID: 1370261
-
Thymic lymphocytes in myasthenia gravis.Ann Neurol. 1977 Apr;1(4):331-3. doi: 10.1002/ana.410010404. Ann Neurol. 1977. PMID: 152595
-
Thymus, thymoma, and specific T cells in myasthenia gravis.Ann N Y Acad Sci. 1998 May 13;841:371-87. doi: 10.1111/j.1749-6632.1998.tb10950.x. Ann N Y Acad Sci. 1998. PMID: 9668262 Review. No abstract available.
-
Role of miRNAs in Normal and Myasthenia Gravis Thymus.Front Immunol. 2020 Jun 10;11:1074. doi: 10.3389/fimmu.2020.01074. eCollection 2020. Front Immunol. 2020. PMID: 32587589 Free PMC article. Review.
Cited by
-
Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues.Am J Pathol. 1993 Nov;143(5):1348-55. Am J Pathol. 1993. PMID: 7694469 Free PMC article.
-
Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?Am J Pathol. 1987 Jun;127(3):447-60. Am J Pathol. 1987. PMID: 2438939 Free PMC article.
-
Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.Am J Pathol. 1988 Sep;132(3):552-62. Am J Pathol. 1988. PMID: 3261946 Free PMC article.
-
Immunopathogenesis and treatment of myasthenia gravis.J Clin Immunol. 1987 May;7(3):187-97. doi: 10.1007/BF00915723. J Clin Immunol. 1987. PMID: 3036906 Review. No abstract available.
-
A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.J Clin Invest. 1998 May 15;101(10):2268-77. doi: 10.1172/JCI2068. J Clin Invest. 1998. PMID: 9593783 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials